Work

Safety and efficacy of ipilimumab in melanoma patients who received prior immunotherapy on phase III study MDX010-020.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.9050

Authors: Howard Kaufman, Jose Lutzky, Joseph Clark, Kim Allyson Margolin, David H. Lawson, Asim Amin, Frances A. Collichio, Andrew Pecora, Walter John Urba, Kelly L. Bennett, David F. McDermott

Institutions: Rush University Medical Center, Mount Sinai Medical Center, Loyola University Medical Center, University of Washington, Emory University, Levine Cancer Institute, University of North Carolina at Chapel Hill, Hackensack University Medical Center, Providence Portland Medical Center, Bristol-Myers Squibb (United States), Dana-Farber Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2586554427

Cites:

Cited by: 4

Related to: 10